Skip to main content
Figure 4 | BMC Urology

Figure 4

From: Casodex treatment induces hypoxia-related gene expression in the LNCaP prostate cancer progression model

Figure 4

RT-PCR of Cyclin G2. RT-PCR was performed as described in Materials and Methods and confirms the presence of Cyclin G2 message expression in LNCaP cells control or treated with 1 μM Casodex for 5 weeks. Cyclin G2 message is indicated (black arrow) at 502 bp. Lane 1, LNCaP-R control. Lane 2, LNCaP-R treated 5 weeks in 1 μM Casodex. Lane 3, LNCaP-UR control. Lane 4, LNCaP-UR treated 5 weeks in 1 μM Casodex.

Back to article page

BMC Urology

ISSN: 1471-2490

Contact us